Under the transaction, Religare Enterprises would sell its entire holding in the life insurance joint venture while existing shareholders -- the Netherlands-based Aegon and Bennett, Coleman & Co Ltd (BCCL) -- would hike their stakes.
Giving its green signal for the deal, CCI said the proposed combination is not likely to have any appreciable adverse effect on competition in India.
Aegon, a global provider of life insurance, pension and asset management, operates in the Indian life insurance space through its shareholding in ARLIC.
Currently, Aegon, BCCL, Religare and K P Corporate Solutions Ltd -- as a trustee for Aegon Religare Employee Benefits Trust -- are the joint venture partners of Aegon Religare Life Insurance Company Ltd (ARLIC).
Also Read
Post deal, Aegon, BCCL and K P Corporate Solutions would have 49 per cent, 48.585 per cent and 2.415 per cent stakes, respectively, in the company.
"It is observed that parties do not provide any similar or identical or substitutable products or services in India.